Association Between GLP-1 Receptor Agonist Use and Worsening Mental Illness in People with Depression and Anxiety in Sweden: a National Cohort Study
Win your appeal pay $25/month with Lilly's savings card
While larger studies are needed to determine whether semaglutide will become a treatment for alcohol use disorder, experts say the research so far is promising.
The signal strengthened in 2026, when a randomized, placebo-controlled trial published in The Lancet reported that adding once-weekly semaglutide to cognitive behavioral therapy produced robust reductions in heavy drinking among participants with alcohol use disorder and obesity [11]
Consider not telling (blinding) one parent, a therapist, or teacher about the treatment and asking for their evaluation of the child
In practice, however, it has become one of the more strategically positioned ingredients in modern womens-health and metabolic-health product development